Artificial intelligence (AI) is rapidly gaining ground in the field of dermatology [1]. While initial technological advancements primarily focused on identifying skin cancers such as melanoma due to the relative ease of standardizing clinical and dermoscopic images [1], researchers and clinicians are now exploring how machine learning can aid in managing complex non-cancerous conditions [7]. Chronic inflammatory skin disorders present unique diagnostic and management hurdles, making them a prime focus for modern digital health research.
Addressing Challenges in Dermatological Care
Modern healthcare systems face critical challenges, including a notable shortage of dermatologists coupled with rising patient demand for specialized care [2]. AI-powered tools hold the potential to help bridge this gap by streamlining clinical evaluations and assisting with routine assessment tasks [2]. Studies indicate that certain AI algorithms can achieve levels of accuracy, sensitivity, and specificity that are comparable to human specialists when evaluating both malignant lesions and common inflammatory conditions [2].
Applications in Inflammatory Skin Conditions
Research into chronic, non-neoplastic dermatologic diseases covers a wide array of conditions, with the most heavily studied being psoriasis, atopic dermatitis or eczema, and acne [7]. AI applications in these areas generally involve clinical evaluation, image analysis, and complex data processing [7]. Specific uses include:
- Assisting clinicians in calculating disease severity scores, such as the Psoriasis Area and Severity Index (PASI) [1].
- Supporting the diagnostic evaluation of hidradenitis suppurativa, atopic dermatitis, and psoriasis [1, 2].
- Integrating supplemental imaging techniques, such as dermoscopy, optical coherence tomography, and reflectance confocal microscopy, to enhance diagnostic precision [2].
- Identifying biomarkers that connect inflammatory skin disorders with psychological factors and anxiety disorders in the developing field of psychodermatology [5].
Current Limitations and Future Directions
Despite promising developments, the integration of artificial intelligence into everyday clinical practice requires caution. Experts emphasize that further prospective and multi-center studies involving diverse patient populations are essential before these tools can be routinely implemented [3]. High-quality, well-structured datasets are mandatory to train algorithms effectively and ensure they perform reliably across varied clinical settings [8]. AI is designed to serve as a supportive diagnostic aid rather than a replacement for professional medical evaluation, ensuring that patients continue to receive comprehensive, personalized care from qualified physicians.
Sources
- 1. Artificial intelligence on inflammatory dermatoses: where we are and where are we going?
- 2. AI-Powered Diagnostic Tools in Dermatology: A Review
- 3. Artificial Intelligence in Inflammatory Bowel Disease
- 4. Artificial intelligence in inflammatory bowel disease
- 5. Artificial Intelligence in psychodermatology: A brief report of applications and impact in clinical practice
- 6. Artificial Intelligence Methods for the Differential Diagnosis of Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Systematic Review
- 7. Emerging Uses of Artificial Intelligence in Chronic Dermatologic Disease: A Scoping Review
- 8. Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis